The anti-PD-1 treatment could significantly inhibit MC38 tumor growth in wild-type mice, while tumor growth inhibition after anti-PD-1 treatment in Cxcl10−/− mice was not as good as in the wild-type mice (Figure 6B). Here, CXCL10 is linked to neoplasm.